Is CHAMPIONS ONCOLOGY, INC. (CSBR) Halal?
Shariah Screening — 5 Standards
Based on financial data from April 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 7.5% / 30% | 12.0% / 30% | 13.8% / 30% | 0.39% / 5% | ✓ HALAL |
| DJIM | 7.5% / 33% | 12.0% / 33% | 13.8% / 33% | 0.39% / 5% | ✓ HALAL |
| MSCI | 18.9% / 33% | 30.3% / 33% | 34.7% / 33% | 0.39% / 5% | ✗ NOT HALAL |
| S&P | 7.5% / 33% | 12.0% / 33% | 13.8% / 33% | 0.39% / 5% | ✓ HALAL |
| FTSE | 18.9% / 33% | 30.3% / 33% | 34.7% / 50% | 0.39% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 45.9% | |
| Operating Margin | -1.1% | |
| Net Margin | -4.0% | |
| Return on Equity (ROE) | -47.6% | |
| Return on Assets (ROA) | -4.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $7M |
| Free Cash Flow | $7M |
| Total Debt | $6M |
| Debt-to-Equity | 114.2 |
| Current Ratio | 1.0 |
| Total Assets | $32M |
Price & Trading
| Last Close | $5.79 |
| 50-Day MA | $6.31 |
| 200-Day MA | $6.77 |
| Avg Volume | 7K |
| Beta | 0.4 |
|
52-Week Range
$5.50
| |
About CHAMPIONS ONCOLOGY, INC. (CSBR)
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Purification Calculator
As a halal stock with 0.39% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CHAMPIONS ONCOLOGY, INC. (CSBR) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CHAMPIONS ONCOLOGY, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CHAMPIONS ONCOLOGY, INC.'s debt ratio?
CHAMPIONS ONCOLOGY, INC.'s debt ratio is 7.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 18.9%.
Does CHAMPIONS ONCOLOGY, INC. require dividend purification?
Yes, CHAMPIONS ONCOLOGY, INC. has an impermissible income ratio of 0.39%, which means 0.39% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are CHAMPIONS ONCOLOGY, INC.'s key financial metrics?
CHAMPIONS ONCOLOGY, INC. has a market capitalization of $80M, and revenue of $57M. The company maintains a gross margin of 45.9% and a net margin of -4.0%. Return on equity stands at -47.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.